InvestorsHub Logo
Followers 1
Posts 171
Boards Moderated 0
Alias Born 07/28/2022

Re: None

Wednesday, 03/01/2023 8:36:25 AM

Wednesday, March 01, 2023 8:36:25 AM

Post# of 75
$TBRIF Therma Bright, Announces Appointment of Dr. John Patton as Chairman to Investee Company InStatin Inc.

Dr. John Patton is recognized as a Leader in the Inhaled Formulation Solutions To Bring Industry Expertise To Innovative, Research-Based Pharmaceutical Firm
Toronto, Ontario--(Newsfile Corp. - March 1, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer and investor in a range of leading-edge and proprietary diagnostic and medical technologies, is pleased to announce that Dr. John Patton has joined as Chairman of InStatin Inc.("InStatin") . InStatin is a privately-held innovative, research-based pharmaceutical company specializing in inhaled therapies, which is a recent Therma Bright investment.

Read full release: https://www.newsfilecorp.com/release/156699/Therma-Bright-Announces-Appointment-of-Dr.-John-Patton-as-Chairman-to-Investee-Company-InStatin-Inc.